These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 17076304)

  • 41. Continuation Electroconvulsive Therapy for Patients With Clozapine-Resistant Schizophrenia: A Pilot Study.
    Braga RJ; John M; Schooler NR; Bailine SH; Malur C; Mendelowitz A; Petrides G
    J ECT; 2019 Sep; 35(3):156-160. PubMed ID: 30973454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
    Vayısoğlu S; Anıl Yağcıoğlu E
    Turk Psikiyatri Derg; 2014; 25(3):201-11. PubMed ID: 25219694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ECT with clozapine: efficacy and safety.
    Trezise K
    Br J Psychiatry; 1996 Nov; 169(5):671. PubMed ID: 8932912
    [No Abstract]   [Full Text] [Related]  

  • 44. Antipsychotic agents used to augment clozapine during long-term inpatient hospitalizations.
    Leung JG; Chengappa KN; Ivanov E; Gandotra G; Kahn CE; Weber JS; Fabian TJ
    Pharmacopsychiatry; 2014 Nov; 47(7):263-7. PubMed ID: 25295551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A review on augmentation of clozapine treatment].
    Anil AE; Turgut IT; Rezaki M; Göğüş A
    Turk Psikiyatri Derg; 2002; 13(1):65-77. PubMed ID: 12792834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The treatment of psychotic depression in patients insufficiently responsive to conventional medication and electroconvulsive therapy; what are the options?].
    Koerhuis MR; Wunderink A; Nolen WA
    Tijdschr Psychiatr; 2008; 50(2):107-12. PubMed ID: 18264902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine.
    Youn T; Jeong SH; Kim YS; Chung IW
    Psychiatry Res; 2019 Mar; 273():759-766. PubMed ID: 31207863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clozapine in schizophrenia patients with recurrent catatonia: report of two cases.
    Hung YY; Yang PS; Huang TL
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):256-8. PubMed ID: 16594953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
    Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clozapine-withdrawal catatonia.
    Bastiampillai T; Forooziya F; Dhillon R
    Aust N Z J Psychiatry; 2009 Mar; 43(3):283-4. PubMed ID: 19230235
    [No Abstract]   [Full Text] [Related]  

  • 52. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
    Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E
    Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clozapine in medication- and electroconvulsive therapy-resistant, depressed inpatients: a case series.
    Quante A; Zeugmann S; Bajbouj M; Anghelescu I
    J Clin Psychopharmacol; 2007 Dec; 27(6):715-7. PubMed ID: 18004147
    [No Abstract]   [Full Text] [Related]  

  • 54. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia.
    Kales HC; Dequardo JR; Tandon R
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Apr; 23(3):547-56. PubMed ID: 10378236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features.
    Craig TJ; Grossman S; Bromet EJ; Fochtmann LJ; Carlson GA
    Compr Psychiatry; 2007; 48(6):497-503. PubMed ID: 17954133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of the stabilization period in electroconvulsive therapy research in schizophrenia: II. Implementation.
    Chanpattana W; Chakrabhand ML; Kirdcharoen N; Tuntirungsee Y; Techakasem P; Prasertsuk Y
    J Med Assoc Thai; 1999 Jun; 82(6):558-68. PubMed ID: 10443077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Electroconvulsive therapy and schizophrenia. Update from the data of the literature].
    Joober R; Bennegadi Z; Olié JP; Lôo H
    Encephale; 1991; 17(4):267-72. PubMed ID: 1683628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia.
    Melzer-Ribeiro DL; Napolitano IC; Leite SA; Alencar de Souza JA; Vizzotto ADB; Di Sarno ES; Fortes M; Gomes ML; de Oliveira GM; Avrichir BS; Talib LL; Correll CU; Elkis H
    Schizophr Res; 2024 Jun; 268():252-260. PubMed ID: 38151432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review.
    Bitter R; Demler TL; Opler L
    J Psychiatr Pract; 2008 Sep; 14(5):265-70. PubMed ID: 18832957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.